Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Ostrov

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Current Allergy and Asthma Reports|March 26, 2018
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and ManagementS Shahzad Mustafa, David Ostrov, Daniel Yerly
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Islet autoantigens: structure, function, localization, and regulationPeter Arvan, Massimo Pietropaolo, David Ostrov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergyRebecca Pavlos, Simon Mallal, David Ostrov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2011
A New Zealand Black-derived locus suppresses chronic graft-versus-host disease and autoantibody production through nonlymphoid bone marrow-derived cellsZhiwei Xu, Anusha Vallurupalli, Christopher Fuhrman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Distinct footprints of TCR engagement with highly homologous ligandsFabio R Santori, Kaisa Holmberg, David Ostrov, et al.
Microbiology Spectrum|February 27, 2023
Machine Learning Prediction and Phyloanatomic Modeling of Viral Neuroadaptive Signatures in the Macaque Model of HIV-Mediated NeuropathologyAndrea S Ramirez-Mata, David Ostrov, Marco Salemi, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Mitoxantrone targets the ATP-binding site of FAK, binds the FAK kinase domain and decreases FAK, Pyk-2, c-Src, and IGF-1R in vitro kinase activitiesVita M Golubovskaya, Baotran Ho, Min Zheng, et al.
Annual Review of Medicine|November 12, 2014
T cell-mediated hypersensitivity reactions to drugsRebecca Pavlos, Simon Mallal, David Ostrov, et al.
The International Journal of Biochemistry & Cell Biology|February 15, 2011
A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastomaPrajit Pillai, Shraddha Desai, Rekha Patel, et al.
Journal of Medicinal Chemistry|November 8, 2008
A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growthVita M Golubovskaya, Carl Nyberg, Min Zheng, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Current Allergy and Asthma Reports|March 26, 2018
Severe Cutaneous Adverse Drug Reactions: Presentation, Risk Factors, and ManagementS Shahzad Mustafa, David Ostrov, Daniel Yerly
Cold Spring Harbor Perspectives in Medicine|August 22, 2012
Islet autoantigens: structure, function, localization, and regulationPeter Arvan, Massimo Pietropaolo, David Ostrov, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergyRebecca Pavlos, Simon Mallal, David Ostrov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 22, 2011
A New Zealand Black-derived locus suppresses chronic graft-versus-host disease and autoantibody production through nonlymphoid bone marrow-derived cellsZhiwei Xu, Anusha Vallurupalli, Christopher Fuhrman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Distinct footprints of TCR engagement with highly homologous ligandsFabio R Santori, Kaisa Holmberg, David Ostrov, et al.
Microbiology Spectrum|February 27, 2023
Machine Learning Prediction and Phyloanatomic Modeling of Viral Neuroadaptive Signatures in the Macaque Model of HIV-Mediated NeuropathologyAndrea S Ramirez-Mata, David Ostrov, Marco Salemi, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 2, 2012
Mitoxantrone targets the ATP-binding site of FAK, binds the FAK kinase domain and decreases FAK, Pyk-2, c-Src, and IGF-1R in vitro kinase activitiesVita M Golubovskaya, Baotran Ho, Min Zheng, et al.
Annual Review of Medicine|November 12, 2014
T cell-mediated hypersensitivity reactions to drugsRebecca Pavlos, Simon Mallal, David Ostrov, et al.
The International Journal of Biochemistry & Cell Biology|February 15, 2011
A novel PKC-ι inhibitor abrogates cell proliferation and induces apoptosis in neuroblastomaPrajit Pillai, Shraddha Desai, Rekha Patel, et al.
Journal of Medicinal Chemistry|November 8, 2008
A small molecule inhibitor, 1,2,4,5-benzenetetraamine tetrahydrochloride, targeting the y397 site of focal adhesion kinase decreases tumor growthVita M Golubovskaya, Carl Nyberg, Min Zheng, et al.
Pageof 3